Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
34.8M
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
33.2M
-
Shares change
-
+6.5M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
+$314M
-
Put/Call ratio
-
0.21
-
Number of buys
-
98
-
Number of sells
-
-51
-
Price
-
$49.64
Significant Holders of Disc Medicine, Inc. - COMMON STOCK (IRON) as of Q1 2025
185 filings reported holding IRON - Disc Medicine, Inc. - COMMON STOCK as of Q1 2025.
Disc Medicine, Inc. - COMMON STOCK (IRON) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.2M shares
of 34.8M outstanding shares and own 95.26% of the company stock.
Largest 10 shareholders include FMR LLC (3.22M shares), Atlas Venture Life Science Advisors, LLC (2.38M shares), WELLINGTON MANAGEMENT GROUP LLP (2.34M shares), BlackRock, Inc. (2.09M shares), Frazier Life Sciences Management, L.P. (1.75M shares), RA CAPITAL MANAGEMENT, L.P. (1.58M shares), JANUS HENDERSON GROUP PLC (1.42M shares), ORBIMED ADVISORS LLC (1.42M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.36M shares), and VANGUARD GROUP INC (1.31M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.